Andrew Cooper

Director, Pharmacovigilance Quality Assurance - GSK

Andrew Cooper is Director of Pharmacovigilance QA at GSK, where he has been working since May 2022. In this role, Andrew is accountable for GSK Pharmacovigilance Enterprise Quality Assurance activities. Prior to this, he served as a QA Manager in the same department from September 2016 to May 2022. Andrew has extensive experience in the field of pharmacovigilance and pharmacovigilance quality assurance. Throughout his 25 year career, he has been involved in numerous projects and initiatives aimed at improving safety and quality in the pharmaceutical industry. He has also been an active participant in professional organizations for example, developing and contributing to industry quality initiatives as well development of tools for safety specifications in risk management plans.